organ growth surprisingli strong despit
tough comp yoy manag maintain ep
guidanc see potenti upsid
double-digit ep growth outlook ep
reiter ow rate pt
surprisingli strong organ growth adjust ep ahead
consensu in-lin estim given tough yoy comp
organ growth twice fast estim
strength across segment human capit benefit hcb vs mse
reinsur irr vs mse benefit deliveri admin bda
vs mse adjust ebitda margin new account vs
mse effect tax rate vs mse fx favor impact
revenu ep
ep upsid despit strong organ growth manag maintain
ep still expect organ growth ebitda
margin share repurchas effect tax rate
compani also re-affirmed investor concern pace
margin expans think yoy underli margin improv
prior account signific despit higher bonu expens
manag achiev origin guidanc past year
organ stronger foot see ep could higher-end
guidanc rang new account impact diminish
could achiev ep given ep growth trajectori
expect buyback ramp repurchas share
anticip neg relat higher bonu payment still
track deliv buyback still expect
buyback averag next quarter see
potenti upsid buyback grow stock pull back
recent account chang creat buy opportun detail
reiter ow increas ep slightli
close high-end guidanc rang
account impact see ep compound-annual-growth-rate period pt
repres ep still discount global peer see potenti
upsid ep price-to-earnings multipl
insur properti casualti unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
exhibit adj op ep in-lin mse consensu
million except per share data
revenu
net incom attribut willi
net debt capit
amount sh repurchas estimate
price target base adjust ep estim ep compound-annual-growth-rate
organ growth margin expans strong capit manag
expect underli cost tax save continu well strong free cash flow
gener materi impact us tax reform valuat expand toward global
global econom uncertainti hurt organ growth inabl execut current
cost save plan litig regulatori issu
illion except per share data
salari benefit
servic ther perat expens
earn ontinu perat axe
provis incom axe
incom earn associ net tax
 et incom attribut lt
adjust et incom attribut lt
adjust ash incom attribut lt
 om mision ee rowth
liabil pension benefit
total equiti attribut lt
statement flow
net provid oper activ
acquisit subsidiari
net use invest activ
repurchas share
net use financ activit
begin period
increas decreas eqival
end period
amount share repurchas
chang commiss fee
chang oper margin
